Teladoc Health, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 660.53 million compared to USD 637.71 million a year ago. Net loss was USD 28.89 million compared to USD 3,810.07 million a year ago. Basic loss per share from continuing operations was USD 0.17 compared to USD 23.49 a year ago.
For the full year, sales was USD 2,602.42 million compared to USD 2,406.84 million a year ago. Net loss was USD 220.37 million compared to USD 13,659.53 million a year ago. Basic loss per share from continuing operations was USD 1.34 compared to USD 84.6 a year ago.